PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
9283719-2	1997	In this study the effect of lovastatin, an inhibitor of cholesterol and isoprenoid synthesis, on the rises in intracellular calcium concentration ([Ca2+]i) induced by platelet derived growth factor BB (PDGF-BB), angiotensin II (AII), low density lipoproteins (LDL) and foetal calf serum (FCS) was examined in human cultured vascular smooth muscle cells (VSMC) from saphenous vein.	Lovastatin	28-38	angiotensinogen	Homo sapiens	212-226	
10205288-6	1999	Lovastatin inhibited, PDGF-, angiotensin II- and PMA-mediated induction.	Lovastatin	0-10	angiotensinogen	Homo sapiens	29-43	
10205288-10	1999	The data demonstrate that lovastatin can suppress PDGF- and angiotensin II-mediated induction of c-Jun and c-Fos protein in human SMC.	Lovastatin	26-36	angiotensinogen	Homo sapiens	60-74	
9283719-2	1997	In this study the effect of lovastatin, an inhibitor of cholesterol and isoprenoid synthesis, on the rises in intracellular calcium concentration ([Ca2+]i) induced by platelet derived growth factor BB (PDGF-BB), angiotensin II (AII), low density lipoproteins (LDL) and foetal calf serum (FCS) was examined in human cultured vascular smooth muscle cells (VSMC) from saphenous vein.	Lovastatin	28-38	angiotensinogen	Homo sapiens	228-231	
9283719-5	1997	Incubation with lovastatin for 24-26 h markedly reduced the peak rise and sustained phase of [Ca2+]i elevation in response to PDGF-BB but the responses to AII, LDL and FCS were unaffected.	Lovastatin	16-26	angiotensinogen	Homo sapiens	155-158	
30926167-0	2019	Lovastatin attenuates angiotensin II induced cardiovascular fibrosis through the suppression of YAP/TAZ signaling.	Lovastatin	0-10	angiotensinogen	Homo sapiens	22-36	
30926167-9	2019	Here, we found that the suppression of YAP/TAZ signaling by lovastatin attenuates ANG II-induced fibrosis, both in vitro and in vivo.	Lovastatin	60-70	angiotensinogen	Homo sapiens	82-88